Logo Logo
Switch Language to German

Kaiser, P.; Peetz, D. and Spannagl, M. (2016): Qualitätssicherung in der Diabetologie. HbA1c-Ringversuche mit Frischblut – etabliert mit kommutablen Probenmaterial. In: Diabetologe, Vol. 12, No. 7: pp. 494-497

Full text not available from 'Open Access LMU'.


HbA(1c) is an important biomarker for diagnosis and therapeutic control of diabetes mellitus. The reliability of the analytical methods used in medical laboratories is thoroughly verified within the quality assurance of the internal and external quality control. The use of commutable, fresh whole blood as control material in ring trials for HbA(1c) will considerably improve therapeuticmanagement and patient safety in the future.

Actions (login required)

View Item View Item